ANDREW M FREEMAN
Allopathic & Osteopathic Physicians|Family Medicine FAYETTEVILLE, NC NPI 1033167697
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NC NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$8,774.98
- Category: General Payments
- Program years: PY2018–2024
- Record count: 42
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $8,214.88 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,015.00 | 4 |
| Food and Beverage | $199.88 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $8,141.08 | 5 |
| ABBVIE INC. | $51.02 | 2 |
| Abbott Laboratories | $22.78 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086945153 | Novartis Pharmaceuticals Corporation | $4,515.00 | 04/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1086945155 | Novartis Pharmaceuticals Corporation | $126.08 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086945167 | Novartis Pharmaceuticals Corporation | $2,450.00 | 07/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1086945173 | Novartis Pharmaceuticals Corporation | $525.00 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1086945175 | Novartis Pharmaceuticals Corporation | $525.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1103752525 | ABBVIE INC. | $29.70 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103752527 | ABBVIE INC. | $21.32 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124804750 | Abbott Laboratories | $22.78 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.